No Data
No Data
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED XL Lamp
The RhodoLED XL is approved by the FDA in combination with Ameluz (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face
10-Q: Quarterly report
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
Q4 2023 Biofrontera Inc Earnings Call
Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules
Biofrontera Misses Q2 Top and Bottom Line Estimates; Reaffirms FY23 Outlook
No Data